
COR · NYSE
Cencora, Inc.
$331.00 -7.29 (-2.15%)
Company overview
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. Its U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals, health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Exchange
- NYSE
- Market cap
- $63.2B
- Employees
- 47,000
- Headquarters
- Conshohocken, PA
- Website
- cencora.com
- CEO
- Robert Mauch
- Listed
- April 4, 1995
- P/E
- 25.23
- Dividend yield
- 0.76%
Company financials
- Revenue
- $329B
- Gross profit
- $11.4B
- Operating income
- $4.2B
- EBITDA
- $4.1B
- Net income
- $2.5B
- EPS
- $13.12
- Total assets
- $81.7B
- Total debt
- $12.4B
- Gross margin
- 3.47%
- Net margin
- 0.78%
- Earnings yield
- 3.96%
Showing FY 2025